Admedus Gets New Interim CFO

On November 26, 2018, Admedus Limited (ASX: AHZ) came forward and made an announcement regarding the appointment of its new interim CFO or chief financial officer named Matthew McDonnell who happens to be the former partner of one of the big four accounting firms named KPMG. The man has worked with the company for more than 24 years which includes a period of 10 years where he was running the firm as a partner. He has a strong experience of the industry, and he has delivered the services related to advisory, audit as well as accounting in different sectors. While he was working at KPMG, he got an opportunity to work in the United States or the US as well as Australia and was handling industrial markets, transport, financial services, energy, childcare as well as health.

The new interim CFO had also worked in the areas which focus on the privatizations as well as restructures of the Queensland Government. His contribution towards the re-listing of the Linc Energy on an exchange which is based in Singapore as well as towards the acquisition of Skywest by Virgin Australia was appreciable. The chief executive officer or CEO of Admedus Limited reflected positive views regarding this appointment. He stated that the appointment would be very much beneficial for strategic finance process. He also believes that strong experience of the range of industries would also be beneficial in regard to the strategy of capital management as the company has plans to work towards further development as well as growth.

Since Matthew has strong capabilities as well as skills related to the managerial finance, governance, management of risk as well as technical accounting matters, the company as well as shareholders would be able to highly benefited. The company has plans to increase the sales of the ADAPT portfolio and is also working towards the product development program. The new interim CFO of the company also has an impressive educational background. The man holds a degree of CA or chartered accountant and has studied the course of Bachelor of Economics which was from the Macquarie University based in New South Wales or NSW. On November 23, 2018, the new interim CFO had started working for Admedus Limited.

Recently, the company reported its quarterly results ending September 30, 2018 in which it managed to deliver $6.3 million. The company stated that its ADAPT sales witnessed a rise of 63% in the September 2018 quarter on PCP or prior corresponding period thanks to the favourable momentum in the EU, United States, favourable fluctuations related to the foreign exchange as well as positive momentum in the emerging markets or EMs. The ADAPT business of North America witnessed robust momentum in sales.

The company’s stock price has been delivering negative returns from the past few months. Within the span of previous six months, the company delivered -43.75%, and in the period of one month, it has given -42.55% return. However, within the span of three months, the company delivered -61.43%. Admedus’s shares were lastly traded on August 01, 2018 at the price of $0.135, implying a market capitalization of $352.89 Mn.


Disclaimer

Sponsored ad by Kalkine

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

 

 

Facebook Comments

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here